Abstract
Type 2 diabetes (T2D) is associated with cognitive decline and dementia. Both neurodegenerative conditions are characterized by olfactory dysfunction (OD) which is also observed in diabetic patients. Diabetes and neurodegeneration display altered miRNAs expression; therefore, the study of miRNAs in the diabetic olfactory system is important in order to know the mechanisms involved in neurodegeneration induced by T2D. In this work we evaluated the expression of miRs206, 451, 146a and 34a in the olfactory bulb (OB) of T2D rats and its association with OD. T2D induction was performed by administering streptozotocin to neonatal rats. The olfactory function was evaluated after reaching the adulthood by employing the buried pellet and social recognition tests. After 18 weeks, animals were sacrificed to determinate miRNAs and protein expression in the OB. T2D animals showed a significant increase in the latency to find the odor stimulus in the buried pellet test and a significant reduction in the interest to investigate the novel juvenile subjects in the social recognition test, indicating OD. In miRNAs analysis we observed a significant increase of miR-146a expression in the OB of T2D rats when compared to controls. This increase in miR-146a correlated with the overexpression of IL-1β in the OB of T2D rats. The present results showed that OD in T2D rats is associated with IL-1β mediated-inflammation and miR-146a overexpression, suggesting that high levels of IL-1β could trigger miR-146a upregulation as a negative feedback of the inflammatory response in the OB of T2D rats.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11064-020-03041-y/MediaObjects/11064_2020_3041_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11064-020-03041-y/MediaObjects/11064_2020_3041_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11064-020-03041-y/MediaObjects/11064_2020_3041_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11064-020-03041-y/MediaObjects/11064_2020_3041_Fig4_HTML.png)
Similar content being viewed by others
References
Zaghloul H, Pallayova M, Al-Nuaimi O et al (2018) Association between diabetes mellitus and olfactory dysfunction: current perspectives and future directions. Diabet Med 35:41–52. https://doi.org/10.1111/dme.13542
Moura J, Børsheim E, Carvalho E (2014) The role of micrornas in diabetic complications—special emphasis on wound healing. Genes (Basel) 5:926–956. https://doi.org/10.3390/genes5040926
Kong APS, Xu G, Brown N et al (2013) Diabetes and its comorbidities - Where East meets West. Nat Rev Endocrinol 9:537–547
Janson J, Laedtke T, Parisi JE et al (2004) Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53:474–481. https://doi.org/10.2337/diabetes.53.2.474
Matsuzaki T, Sasaki K, Tanizaki Y et al (2010) Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology 75:764–770. https://doi.org/10.1212/WNL.0b013e3181eee25f
Umegaki H (2009) Pathophysiology of cognitive dysfunction in older people with type 2 diabetes: vascular changes or neurodegeneration? Age Ageing 39:8–10
Strachan MWJ, Reynolds RM, Marioni RE, Price JF (2011) Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol 7:108–114. https://doi.org/10.1038/nrendo.2010.228
Lietzau G, Davidsson W, Östenson CG et al (2018) Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin. Acta Neuropathol Commun 6:1–15. https://doi.org/10.1186/s40478-018-0517-1
Croy I, Nordin S, Hummel T (2014) Olfactory disorders and quality of life-an updated review. Chem Senses 39:185–194. https://doi.org/10.1093/chemse/bjt072
Tian S, Huang R, Han J et al (2018) Increased plasma Interleukin-1β level is associated with memory deficits in type 2 diabetic patients with mild cognitive impairment. Psychoneuroendocrinology 96:148–154. https://doi.org/10.1016/j.psyneuen.2018.06.014
**e Y, Chu A, Feng Y et al (2018) MicroRNA-146a: a comprehensive indicator of inflammation and oxidative stress status induced in the brain of chronic T2DM rats. Front Pharmacol 9:1–11. https://doi.org/10.3389/fphar.2018.00478
Codocedo JF, Ríos JA, Godoy JA, Inestrosa NC (2016) Are microRNAs the molecular link between metabolic syndrome and Alzheimer’s disease? Mol Neurobiol 53:2320–2338. https://doi.org/10.1007/s12035-015-9201-7
Gebert LFR, MacRae IJ (2019) Regulation of microRNA function in animals. Nat Rev Mol Cell Biol 20:21–37. https://doi.org/10.1038/s41580-018-0045-7
Behm-Ansmant I, Rehwinkel J, Izaurralde E (2006) MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay. Cold Spring Harbor Sympnew osia on Quantitative Biology. Cold Spring Harbor Laboratory Press, New York, pp 523–530
Miao C, Zhang G, **e Z, Chang J (2018) MicroRNAs in the pathogenesis of type 2 diabetes: new research progress and future direction. Can J Physiol Pharmacol 96:103–112. https://doi.org/10.1139/cjpp-2017-0452
Zhang Y, Sun X, Icli B, Feinberg MW (2017) Emerging roles for MicroRNAs in diabetic microvascular disease: novel targets for therapy. Endocr Rev 38:145–168. https://doi.org/10.1210/er.2016-1122
Natarajan R, Putta S, Kato M (2012) MicroRNAs and diabetic complications. J Cardiovasc Transl Res 5:413–422. https://doi.org/10.1007/s12265-012-9368-5
Maciotta S, Meregalli M, Torrente Y (2013) The involvement of microRNAs in neurodegenerative diseases. Front Cell Neurosci 7:1–17. https://doi.org/10.3389/fncel.2013.00265
Hernandez-rapp J, Rainone S, Hébert SS (2017) Progress in neuro-psychopharmacology & biological psychiatry MicroRNAs underlying memory de fi cits in neurodegenerative disorders. Prog Neuropsychopharmacol Biol Psychiatry 73:79–86. https://doi.org/10.1016/j.pnpbp.2016.04.011
Kolfschoten IGM, Roggli E, Nesca V, Regazzi R (2009) Role and therapeutic potential of microRNAs in diabetes. Diabetes Obes Metab 11:118–129. https://doi.org/10.1111/j.1463-1326.2009.01118.x
Karolina DS, Armugam A, Sepramaniam S, Jeyaseelan K (2012) MiRNAs and diabetes mellitus. Expert Rev Endocrinol Metab 7:281–300. https://doi.org/10.1586/eem.12.21
Seyhan AA, Nunez Lopez YO, **e H et al (2016) Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study. Sci Rep 6:31479. https://doi.org/10.1038/srep31479
Gong Q, Su G (2017) Roles of miRNAs and long noncoding RNAs in the progression of diabetic retinopathy. Biosci Rep. https://doi.org/10.1042/BSR20171157
Moon J, Lee S-T, Kong IG et al (2016) Early diagnosis of Alzheimer’s disease from elevated olfactory mucosal miR-206 level. Sci Rep 6:20364. https://doi.org/10.1038/srep20364
Lin Y, Shen J, Li D et al (2017) MiR-34a contributes to diabetes-related cochlear hair cell apoptosis via SIRT1/HIF-1α signaling. Gen Comp Endocrinol 246:63–70. https://doi.org/10.1016/j.ygcen.2017.02.017
Zhuo S, Yang M, Zhao Y et al (2016) MicroRNA-451 negatively regulates hepatic glucose production and glucose homeostasis by targeting glycerol kinase-mediated gluconeogenesis. Diabetes 65:3276–3288. https://doi.org/10.2337/db16-0166
Alsharafi WA, **ao B, Abuhamed MM et al (2015) Correlation between IL-10 and microRNA-187 expression in epileptic rat hippocampus and patients with temporal lobe epilepsy. Front Cell Neurosci 9:466. https://doi.org/10.3389/fncel.2015.00466
Kumarswamy R, Lyon AR, Volkmann I et al (2012) SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway. Eur Heart J 33:1067–1075. https://doi.org/10.1093/eurheartj/ehs043
Mavrikaki M, Anastasiadou E, Ozdemir RA et al (2019) Overexpression of miR-9 in the nucleus accumbens increases oxycodone self-administration. Int J Neuropsychopharmacol 22:383–393. https://doi.org/10.1093/ijnp/pyz015
Machado C, Reis-Silva T, Lyra C et al (2018) Buried food-seeking test for the assessment of olfactory detection in mice. BIO-PROTOCOL. https://doi.org/10.21769/bioprotoc.2897
Jacobs S, Huang F, Tsien J, Wei W (2016) Social recognition memory test in rodents. BIO-PROTOCOL. https://doi.org/10.21769/bioprotoc.1804
Jacobs SA, Tsien JZ (2014) Overexpression of the NR2A subunit in the forebrain impairs long-term social recognition and non-social olfactory memory. Genes Brain Behav 13:376–384. https://doi.org/10.1111/gbb.12123
Almeida-Santos AF, Carvalho VR, Jaimes LF et al (2019) Social isolation impairs the persistence of social recognition memory by disturbing the glutamatergic tonus and the olfactory bulb-dorsal hippocampus coupling. Sci Rep 9:1–13. https://doi.org/10.1038/s41598-018-36871-6
Zhang L, Chopp M, Zhang Y et al (2016) Diabetes mellitus impairs cognitive function in middle-aged rats and neurological recovery in middle-aged rats after stroke. Stroke 47:2112–2118. https://doi.org/10.1161/STROKEAHA.115.012578
Wang RN, Bouwens L, Klöppel G (1996) Beta-cell growth in adolescent and adult rats treated with streptozotocin during the neonatal period. Diabetologia 39:548–557. https://doi.org/10.1007/BF00403301
Tourrel C, Bailbé D, Meile MJ et al (2001) Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes 50:1562–1570. https://doi.org/10.2337/diabetes.50.7.1562
Schaffer SW, Wilson GL (1993) Insulin resistance and mechanical dysfunction in hearts of Wistar rats with streptozotocin-induced non-insulin-dependent diabetes mellitus. Diabetologia 36:195–199. https://doi.org/10.1007/bf00399949
Takada J, Machado MA, Peres SB et al (2007) Neonatal streptozotocin-induced diabetes mellitus: a model of insulin resistance associated with loss of adipose mass. Metabolism 56:977–984. https://doi.org/10.1016/j.metabol.2006.05.021
Liang X-D, Guo Y-Y, Sun M et al (2011) Streptozotocin-induced expression of Ngn3 and Pax4 in neonatal rat pancreatic α-cells. World J Gastroenterol 17:2812–2820. https://doi.org/10.3748/wjg.v17.i23.2812
Hemmings SJ, Spafford D (2000) Neonatal STZ model of type II diabetes mellitus in the Fischer 344 rat: characteristics and assessment of the status of the hepatic adrenergic receptors. Int J Biochem Cell Biol 32:905–919. https://doi.org/10.1016/S1357-2725(00)00019-4
Barragán-iglesias P, Oidor-chan VH, Loeza-alcocer E et al (2018) Pharmacological reports evaluation of the neonatal streptozotocin model of diabetes in rats : evidence for a model of neuropathic pain. Pharmacol Rep 70:294–303. https://doi.org/10.1016/j.pharep.2017.09.002
Patil MA, Suryanarayana P, Putcha UK et al (2014) Evaluation of neonatal streptozotocin induced diabetic rat model for the development of cataract. Oxid Med Cell Longev 2014:463264. https://doi.org/10.1155/2014/463264
Rivière S, Soubeyre V, Jarriault D et al (2016) High fructose diet inducing diabetes rapidly impacts olfactory epithelium and behavior in mice. Sci Rep 6:1–13. https://doi.org/10.1038/srep34011
Faizal M (2017) A histomorphological study on the olfactory bulb of diabetic albino rats. Int J Clin Exp Med Sci 3:47. https://doi.org/10.11648/j.ijcems.20170304.12
Julliard A-K, Al Koborssy D, Fadool DA, Palouzier-Paulignan B (2017) Nutrient sensing: another chemosensitivity of the olfactory system. Front Physiol 8:468. https://doi.org/10.3389/fphys.2017.00468
Aimé P, Hegoburu C, Jaillard T et al (2012) A physiological increase of insulin in the olfactory bulb decreases detection of a learned aversive odor and abolishes food odor-induced sniffing behavior in rats. PLoS ONE. https://doi.org/10.1371/journal.pone.0051227
Palouzier-Paulignan B, Lacroix M-C, Aimé P et al (2012) Olfaction under metabolic influences equal contribution. Chem Senses 37:769–797. https://doi.org/10.1093/chemse/bjs059
Fadool DA, Tucker K, Phillips JJ, Simmen JA (2000) Brain insulin receptor causes activity-dependent current suppression in the olfactory bulb through multiple phosphorylation of Kv1.3. J Neurophysiol 83:2332–2348. https://doi.org/10.1152/jn.2000.83.4.2332
Shimshek DR, Bus T, Kim J et al (2005) Enhanced odor discrimination and impaired olfactory memory by spatially controlled switch of AMPA receptors. PLoS Biol 3:e354. https://doi.org/10.1371/journal.pbio.0030354
Lietzau G, Nyström T, Östenson CG et al (2016) Type 2 diabetes-induced neuronal pathology in the piriform cortex of the rat is reversed by the GLP-1 receptor agonist Exendin-4. Oncotarget 7:5865–5876. https://doi.org/10.18632/oncotarget.6823
Roberts RO, Christianson TJH, Kremers WK et al (2016) Association between olfactory dysfunction and amnestic mild cognitive impairment and Alzheimer disease dementia. JAMA Neurol 73:93–101. https://doi.org/10.1001/jamaneurol.2015.2952
Dintica CS, Marseglia A, Rizzuto D et al (2019) Impaired olfaction is associated with cognitive decline and neurodegeneration in the brain. Neurology 92:E700–E709. https://doi.org/10.1212/WNL.0000000000006919
Sayilar EI (2016) Biomarker potential of urine miR-451 at different stages of diabetic nephropathy. J Diabetes Metab. https://doi.org/10.4172/2155-6156.1000650
Ayers D, Scerri C (2018) Non-coding RNA influences in dementia. Non-coding RNA Res 3:188–194. https://doi.org/10.1016/j.ncrna.2018.09.002
Mai H, Fan W, Wang Y et al (2019) Intranasal administration of miR-146a agomir rescued the pathological process and cognitive impairment in an AD mouse model. Mol Ther Nucleic Acids 18:681–695. https://doi.org/10.1016/j.omtn.2019.10.002
Kalani A, Chaturvedi P, Maldonado C et al (2017) Dementia-like pathology in type-2 diabetes: a novel microRNA mechanism. Mol Cell Neurosci 80:58–65. https://doi.org/10.1016/j.mcn.2017.02.005
Kong L, Zhu J, Han W et al (2011) Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol 48:61–69. https://doi.org/10.1007/s00592-010-0226-0
Cava C, Manna I, Gambardella A et al (2018) Potential role of miRNAs as theranostic biomarkers of epilepsy. Mol Ther Nucleic Acids 13:275–290. https://doi.org/10.1016/j.omtn.2018.09.008
Iyer A, Zurolo E, Prabowo A et al (2012) MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS ONE 7:17–19. https://doi.org/10.1371/journal.pone.0044789
Shaik MM, Tamargo IA, Abubakar MB et al (2018) The role of microRNAs in Alzheimer’s disease and their therapeutic potentials. Genes (Basel). https://doi.org/10.3390/genes9040174
Slota JA, Booth SA (2019) MicroRNAs in neuroinflammation: Implications in disease pathogenesis, biomarker discovery and therapeutic applications. Non-coding RNA. https://doi.org/10.3390/ncrna5020035
Li G, Ling S (2017) MiR-124 promotes newborn olfactory bulb neuron dendritic morphogenesis and spine density. J Mol Neurosci 61:159–168. https://doi.org/10.1007/s12031-016-0873-x
Åkerblom M, Sachdeva R, Barde I et al (2012) MicroRNA-124 is a subventricular zone neuronal fate determinant. J Neurosci 32:8879–8889. https://doi.org/10.1523/JNEUROSCI.0558-12.2012
Stappert L, Klaus F, Brüstle O (2018) MicroRNAs engage in complex circuits regulating adult neurogenesis. Front Neurosci 12:707
Sun T, Li S, Yang J et al (2014) Identification of a microRNA regulator for axon guidance in the olfactory bulb of adult mice. Gene 547:319–328. https://doi.org/10.1016/j.gene.2014.06.063
Acknowledgements
This work was supported by Grants from the Fondo Sectorial de Investigación en Salud y Seguridad Social Convocatoria 2015-01 by the Consejo Nacional de Ciencia y Tecnología, CONACyT (261481), and a postdoctoral fellowship (Adriana Jiménez) from Programa de Becas Posdoctorales de la Dirección General de Asuntos del Personal Académico (DGAPA), División de Investigación, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM). The authors wish to thank Mrs. Josefina Bolado, Head of the Scientific Paper Translation Department from División de Investigación at Facultad de Medicina, UNAM.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors declared that they do not have any conflict of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jiménez, A., Organista-Juárez, D., Torres-Castro, A. et al. Olfactory Dysfunction in Diabetic Rats is Associated with miR-146a Overexpression and Inflammation. Neurochem Res 45, 1781–1790 (2020). https://doi.org/10.1007/s11064-020-03041-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-020-03041-y